BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 2555848)

  • 1. The pathogenesis of Lyme disease.
    Garcia-Monco JC; Benach JL
    Rheum Dis Clin North Am; 1989 Nov; 15(4):711-26. PubMed ID: 2555848
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Central and peripheral nervous system infection, immunity, and inflammation in the NHP model of Lyme borreliosis.
    Pachner AR; Cadavid D; Shu G; Dail D; Pachner S; Hodzic E; Barthold SW
    Ann Neurol; 2001 Sep; 50(3):330-8. PubMed ID: 11558789
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lyme borreliosis: from infection to autoimmunity.
    Singh SK; Girschick HJ
    Clin Microbiol Infect; 2004 Jul; 10(7):598-614. PubMed ID: 15214872
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Pathomechanisms of neuroborreliosis].
    Garcia-Monco JC
    Wien Med Wochenschr; 1995; 145(7-8):174-7. PubMed ID: 7610667
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Selected aspects of immunopathogenesis in Lyme disease].
    Zajkowska JM; Hermanowska-Szpakowicz T; Pancewicz SA; Kondrusik M
    Pol Merkur Lekarski; 2000 Aug; 9(50):579-83. PubMed ID: 11081331
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathogenesis of neuroborreliosis--lessons from a monkey model.
    Pachner AR; Schaefer H; Amemiya K; Cadavid D; Zhang WF; Reddy K; O'Neill T
    Wien Klin Wochenschr; 1998 Dec; 110(24):870-3. PubMed ID: 10048168
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural identification of a key protective B-cell epitope in Lyme disease antigen OspA.
    Ding W; Huang X; Yang X; Dunn JJ; Luft BJ; Koide S; Lawson CL
    J Mol Biol; 2000 Oct; 302(5):1153-64. PubMed ID: 11183781
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Spirochetal diseases of the CNS.
    Pachner AR
    Neurol Clin; 1986 Feb; 4(1):207-22. PubMed ID: 3724737
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Borrelia burgdorferi outer membrane protein A induces nuclear translocation of nuclear factor-kappa B and inflammatory activation in human endothelial cells.
    Wooten RM; Modur VR; McIntyre TM; Weis JJ
    J Immunol; 1996 Nov; 157(10):4584-90. PubMed ID: 8906837
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [New aspects of the pathogenesis of lyme disease].
    Zajkowska JM; Hermanowska-Szpakowicz T
    Przegl Epidemiol; 2002; 56 Suppl 1():57-67. PubMed ID: 12194230
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Histopathology of clinical phases of human Lyme disease.
    Duray PH
    Rheum Dis Clin North Am; 1989 Nov; 15(4):691-710. PubMed ID: 2685926
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Lyme disease: an infection with localization in various organs].
    Kuiper H; van Doornum GJ
    Ned Tijdschr Geneeskd; 1987 Aug; 131(31):1361. PubMed ID: 2821410
    [No Abstract]   [Full Text] [Related]  

  • 13. Polymerase chain reaction in diagnosis of Borrelia burgdorferi infections and studies on taxonomic classification.
    Lebech AM
    APMIS Suppl; 2002; (105):1-40. PubMed ID: 11985118
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preferential usage of T cell antigen receptor V region gene segment V beta 5.1 by Borrelia burgdorferi antigen-reactive T cell clones isolated from a patient with Lyme disease.
    Lahesmaa R; Shanafelt MC; Allsup A; Soderberg C; Anzola J; Freitas V; Turck C; Steinman L; Peltz G
    J Immunol; 1993 May; 150(9):4125-35. PubMed ID: 7682589
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Counterpoint: long-term antibiotic therapy improves persistent symptoms associated with lyme disease.
    Stricker RB
    Clin Infect Dis; 2007 Jul; 45(2):149-57. PubMed ID: 17578772
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of candidate T-cell epitopes and molecular mimics in chronic Lyme disease.
    Hemmer B; Gran B; Zhao Y; Marques A; Pascal J; Tzou A; Kondo T; Cortese I; Bielekova B; Straus SE; McFarland HF; Houghten R; Simon R; Pinilla C; Martin R
    Nat Med; 1999 Dec; 5(12):1375-82. PubMed ID: 10581079
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Immunopathology of Lyme arthritis].
    Pancewicz SA; Rutkowski R; Rutkowski K; Zajkowska JM; Kondrusik M
    Pol Merkur Lekarski; 2007 Aug; 23(134):141-4. PubMed ID: 18044347
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Immunochemical analysis of the immune response in late manifestations of Lyme borreliosis].
    Wilske B; Preac-Mursic V; Schierz G; Gueye W; Herzer P; Weber K
    Zentralbl Bakteriol Mikrobiol Hyg A; 1988 Mar; 267(4):549-58. PubMed ID: 3381603
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Studies on the pathogenesis and treatment of Lyme arthritis.
    Franz JK; Priem S; Rittig MG; Burmester GR; Krause A
    Wien Klin Wochenschr; 1999 Dec; 111(22-23):981-4. PubMed ID: 10666814
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of Lyme borreliosis.
    Luft BJ; Dattwyler RJ
    Rheum Dis Clin North Am; 1989 Nov; 15(4):747-55. PubMed ID: 2555849
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.